Rania Chehade

709 total citations
21 papers, 485 citations indexed

About

Rania Chehade is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rania Chehade has authored 21 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Rania Chehade's work include Lung Cancer Research Studies (10 papers), Brain Metastases and Treatment (9 papers) and Ovarian cancer diagnosis and treatment (4 papers). Rania Chehade is often cited by papers focused on Lung Cancer Research Studies (10 papers), Brain Metastases and Treatment (9 papers) and Ovarian cancer diagnosis and treatment (4 papers). Rania Chehade collaborates with scholars based in Canada and United States. Rania Chehade's co-authors include Jacques Raphael, Gabriel Boldt, Ricardo Fernandes, Saman Maleki Vareki, Phillip Blanchette, S. M. Qasim Hussaini, Ali Fatehi Hassanabad, Daniel Breadner, Katarzyna J. Jerzak and Patricia A. Shaw and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Annals of Oncology.

In The Last Decade

Rania Chehade

19 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rania Chehade Canada 8 327 174 125 79 66 21 485
Gustavo Schvartsman Brazil 11 370 1.1× 201 1.2× 101 0.8× 118 1.5× 56 0.8× 31 488
Audrey Simonaggio France 10 445 1.4× 278 1.6× 104 0.8× 48 0.6× 82 1.2× 23 567
Hidekazu Hirano Japan 12 368 1.1× 225 1.3× 141 1.1× 158 2.0× 65 1.0× 91 586
Valentina Tateo Italy 10 205 0.6× 150 0.9× 114 0.9× 106 1.3× 44 0.7× 36 437
Gregory Pennock United States 8 384 1.2× 132 0.8× 113 0.9× 74 0.9× 153 2.3× 22 527
Chaitali Nangia United States 9 197 0.6× 158 0.9× 77 0.6× 55 0.7× 43 0.7× 34 330
Christopher DiSimone United States 6 271 0.8× 148 0.9× 114 0.9× 71 0.9× 58 0.9× 10 490
Laure Hirsch France 9 297 0.9× 246 1.4× 183 1.5× 45 0.6× 104 1.6× 16 517
Gerry Gin Wai Kwok China 7 343 1.0× 109 0.6× 79 0.6× 60 0.8× 131 2.0× 10 518
Chukwuemeka Ikpeazu United States 9 189 0.6× 144 0.8× 119 1.0× 42 0.5× 44 0.7× 23 356

Countries citing papers authored by Rania Chehade

Since Specialization
Citations

This map shows the geographic impact of Rania Chehade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rania Chehade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rania Chehade more than expected).

Fields of papers citing papers by Rania Chehade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rania Chehade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rania Chehade. The network helps show where Rania Chehade may publish in the future.

Co-authorship network of co-authors of Rania Chehade

This figure shows the co-authorship network connecting the top 25 collaborators of Rania Chehade. A scholar is included among the top collaborators of Rania Chehade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rania Chehade. Rania Chehade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Kevin Yijun, Rania Chehade, Veronika Moravan, et al.. (2025). Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study. JCO Precision Oncology. 9(9). e2400641–e2400641.
3.
Chehade, Rania, et al.. (2024). PARP inhibitors in non-ovarian gynecologic cancers. Therapeutic Advances in Medical Oncology. 16. 12699910–12699910. 2 indexed citations
4.
Chehade, Rania, Katarzyna J. Jerzak, Anna Plotkin, et al.. (2024). Advances in Vulvar Cancer Biology and Management. Journal of Clinical Oncology. 43(1). 89–100. 4 indexed citations
5.
Chehade, Rania, Sharon Nofech‐Mozes, Anna Plotkin, et al.. (2024). Human Epidermal Growth Factor Receptor 2–Low Breast Cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population. JCO Precision Oncology. 8(8). e2300487–e2300487. 4 indexed citations
6.
Fan, Kevin Yijun, et al.. (2024). Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey. Current Oncology. 31(5). 2610–2619. 1 indexed citations
7.
Fan, Kevin Yijun, Rania Chehade, Maleeha Qazi, et al.. (2023). Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent. Cancers. 15(10). 2748–2748. 4 indexed citations
8.
Chehade, Rania, et al.. (2023). Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer—A Literature Review. Cancers. 15(17). 4336–4336. 1 indexed citations
9.
Chehade, Rania, Veronika Moravan, Arjun Sahgal, et al.. (2023). Brain Metastases in the Setting of Stable Versus Progressing Extracranial Disease Among Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 24(2). 156–161. 1 indexed citations
10.
Chehade, Rania, Sharon Nofech‐Mozes, Anna Plotkin, Veronika Moravan, & Katarzyna J. Jerzak. (2023). HER2-LOW BREAST CANCER BRAIN METASTASES: INCIDENCE AND TREATMENT IMPLICATIONS. Neuro-Oncology Advances. 5(Supplement_2). i8–i8. 1 indexed citations
11.
Chehade, Rania, et al.. (2022). 53P ‘HER2-LOW’ breast cancer brain metastases: An opportunity for targeted systemic therapies in a high-need patient population. Annals of Oncology. 33. S145–S145. 2 indexed citations
12.
Chehade, Rania, Arjun Sahgal, Sunit Das, et al.. (2022). Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada. JAMA Network Open. 5(8). e2225424–e2225424. 14 indexed citations
13.
Chehade, Rania, Arif Awan, & Ricardo M. Fernandes. (2021). A narrative review of biomarkers in advanced triple negative breast cancer. 4. 24–24. 3 indexed citations
14.
Gao, Yizhuo, Markus Kuksis, Rania Chehade, et al.. (2021). Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective Study. The Oncologist. 26(11). e1951–e1961. 13 indexed citations
15.
Hussaini, S. M. Qasim, Rania Chehade, Gabriel Boldt, et al.. (2020). Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis. Cancer Treatment Reviews. 92. 102134–102134. 264 indexed citations
16.
Hassanabad, Ali Fatehi, Rania Chehade, Daniel Breadner, & Jacques Raphael. (2019). Esophageal carcinoma: Towards targeted therapies. Cellular Oncology. 43(2). 195–209. 112 indexed citations
18.
Chehade, Rania, Leonardo Salmena, Max Kotlyar, et al.. (2016). Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific. Breast Cancer Research. 18(1). 87–87. 9 indexed citations
19.
Kotlyar, Max, Rania Chehade, Leonardo Salmena, et al.. (2015). Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene Expression. Cancer Prevention Research. 9(1). 83–88. 12 indexed citations
20.
George, Sophia, et al.. (2015). Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. Oncogene. 35(1). 59–68. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026